Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective
forty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I or group II. the group enroled 20 seniors. both groups wil take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| group number 1 | Experimental | twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will bein group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks. |
|
| group number 2 | Active Comparator | Twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II oand this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Buteyko breathing | Other | twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| Eustachian Tube Dysfunction Questionnaire | it will be used to asses symptoms of Eustachian Tube Dysfunction | it will be measured after 2 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| systolic blood pressure | it will be measured manually by manual sphygmomanometer | it will be measured after 2 weeks |
| diastolic blood pressure | it will be measured manually by manual sphygmomanometer |
Not provided
Inclusion Criteria:
Exclusion Criteria:
based on self-representation of gender identity.
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ali MA Ismail, lecturer | Contact | 01005154209 | ali.mohamed@pt.cu.edu.eg | |
| Ali mohamed, lecturer | Contact | allooka2012@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Ali MA Ismail, lecturer | Cairo University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cairo University | Recruiting | Dokki | Giza Governorate | 11432 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| usual care | Other | twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. |
|
| it will be measured after 2 weeks |
| respiratory rate | it will assess breath number per minute | it will be measured after 2 weeks |
| pulse rate | it will assess pulse number per minute from radial artery | it will be measured after 2 weeks |
| patient health questionnaire | it will assess depression in patients | it will be measured after 2 weeks |
| state trait anxiety inventory | it will assess trait anxiety in patients | it will be measured after 2 weeks |
| perceived stress scale | it will assess stress in patients | it will be measured after 2 weeks |
| short form 36 questionnaire | it will assess quality of life in patients | it will be measured after 2 weeks |
| profile of mood satus | it will assess mood in patients | it will be measured after 2 weeks |
| percenatge of tympanometry (type C) | it will assess percenatge of type c tympanometry | it will be measured after 2 weeks |